medigraphic.com
ISSN 0185-6014 (Impreso)
Órgano oficial de difusión de la Federación Mexicana de Patología Clínica, AC y de la Asociación Latinoamericana de Patología Clínica/Medicina de Laboratorio

2016, Número 4

<< Anterior Siguiente >>

Rev Mex Patol Clin Med Lab 2016; 63 (4)


Diagnóstico y tratamiento de infecciones causadas por Helicobacter pylori

Cervantes GE

Idioma: Español
Referencias bibliográficas: 84
Paginas: 179-189
Archivo PDF: 329.61 Kb.


RESUMEN

La infección por Helicobacter pylori (H. pylori) se adquiere durante la infancia, desarrollando una respuesta inflamatoria y erosión de la mucosa gástrica en más de 50% de la población mundial. Se ha reconocido como agente etiológico en el desarrollo de úlcera, gastritis crónica, cáncer gástrico y linfoma del tejido linfoide asociado a la mucosa gástrica (MALT). Durante la infección se pueden presentar signos y síntomas como dolor, náuseas, dispepsia, pérdida de peso. Debido al potencial patogénico que se ha detectado en esta bacteria, es necesario contar con métodos eficaces de diagnóstico para su detección y llevar a cabo un tratamiento eficaz. Las técnicas empleadas para el diagnóstico de la infección por H. pylori se pueden dividir en métodos invasivos como la endoscopia gástrica para la obtención de biopsias, cultivo, PCR, y técnicas no invasivas, que son menos agresivas para el paciente. Esta revisión constituye una actualización de las principales técnicas utilizadas para el diagnóstico de H. pylori y los tratamientos que existen hasta este momento.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Mentis A, Lehours P, Mégraud F. Epidemiology and diagnosis of Helicobacter pylori infection. Helicobacter. 2015; 20: 1-7.

  2. Calvet X, Ramirez-Lázaro MJ, Lehours P, Mégraud F. Diagnosis and epidemiology of Helicobacter pylori infection. Helicobacter. 2013; 18: 5-11.

  3. Cervantes-Garcá E. Helicobacter pylori e infecciones asociadas. Rev Fac Med, UNAM. 2006; 49: 163-168.

  4. Morgan DR, Crowe SE. Heliobacter pylori infection. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger and Fordtran’s gastrointestinal and liver disease: Pathophysiology/Diagnosis/Management. Chap 51. 10th ed. Philadelphia, PA: Elsevier Saunders; 2016.

  5. Lee HC, Huang TC, Lin CL, Chen KY, Wang CK, Wu DC. Performance of rutine Helicobacter pylori invasive tests in patients with dispepsia. Gastroenterol Res Pract. 2013; 2013: 184806.

  6. Hirschl AM, Makristathis A. Methods to detect Helicobacter pylori: from culture to molecular biology. Helicobacter. 2007; 12: 6-11.

  7. Ricci C, Holton J, Vaira D. Diagnosis of Helicobacter pylori: invasive and non- invasive tests. Best Pract Res Clin Gastroenterol. 2007; 21: 299-313.

  8. Patel SK, Pratap CB, Jain AK, Gulati AK, Nath G. Diagnosis of Helicobacter pylori: what should be the gold standard? World J Gastroenterol. 2014; 20: 12847-12859.

  9. Laine L, Lewin DN, Naritoku W, Cohen H. Prospective comparison of H&E, Giemsa, and Genta stains for the diagnosis of Helicobacter pylori. Gastrointest Endosc. 1997; 45: 463-467.

  10. Fallone CA, Loo VG, Lough J, Barkun AN. Hematoxylin and eosin staining of gastric tissue for the detection of Helicobacter pylori. Helicobacter. 1997; 2: 32-35.

  11. El-Zimaity HM, Segura AM, Genta RM, Graham DY. Histologic assessment of Helicobacter pylori status after therapy: comparison of Giemsa, Diff-Quik, and Genta stains. Mod Pathol. 1998; 11: 288-291.

  12. Eshun JK, Black DD, Casteel HB, Horn H, Beavers-May T, Jetton CA et al. Comparison of immunohistochemistry and silver stain for the diagnosis of pediatric Helicobacter pylori infection in urease-negative gastric biopsies. Pediatr Dev Pathol. 2001; 4: 82-88.

  13. Rüssmann H, Kempf VA, Koletzko S, Heesemann J, Autenrieth IB. Comparison of fluorescent in situ hybridization and conventional culturing for detection of Helicobacter pylori in gastric biopsy specimens. J Clin Microbiol. 2001; 39: 304-308.

  14. Trebesius K, Panthel K, Strobel S, Vogt K, Faller G, Kirchner T et al. Rapid and specific detection of Helicobacter pylori macrolide resistance in gastric tissue by fluorescent in situ hybridisation. Gut. 2000; 46: 608-614.

  15. Samarbaf-Zadeh AR, Tajbakhsh S, Moosavian SM, Sadeghi-Zadeh M, Azmi M, Hashemi J et al. Application of fluorescent in situ hybridization (FISH) for the detection of Helicobacter pylori. Med Sci Monit. 2007; 12: CR426-430.

  16. Windsor HM, Abioye-Kuteyi EA, Marshall BJ. Methodology and transport medium for collection of Helicobacter pylori on a string test in remote locations. Helicobacter. 2005; 10: 630-634.

  17. Fresnadillo-Martínez MJ, Rodríguez-Rincón M, Blázquez de Castro AM, García-Sánchez E, García-Sánchez JE, Trujillano-Martín I et al. Comparative evaluation of selective and nonselective media for primary isolation of Helicobacter pylori from gastric biopsies. Helicobacter. 1997; 2 (1): 36-39.

  18. Withmire JM, Merrell DS. Successful culture techniques of Helicobacter species: general culture techniques for Helicobacter pylori. Methods Mol Biol. 2012; 921: 17-27.

  19. Ndip RN, MacKay WG, Farthing MJ, Weaver LT. Culturing Helicobacter pylori from clinical specimens: review of microbiologic methods. J Pediatr Gastroenterol Nutr. 2003; 36: 616-622.

  20. Perez-Perez GI. Accurate diagnosis of Helicobacter pylori. Culture, including transport. Gastroenterol Clin North Am. 2000; 29: 879-884.

  21. Uotani T, Graham DY. Diagnosis of Helicobacter pylori using rapid urease test. Ann Transl Med. 2015; 3: 9.

  22. Moon SW, Kim TH, Kim HS, Ju JH, Ahn YJ, Jang HJ et al. United rapid urease test is superior than separate test in detecting Helicobacter pylori at the gastric antrum and body specimens. Clin Endosc. 2012; 45 (4): 392-396.

  23. Tseng CA, Wang WM, Wu DC. Comparison of the clinical feasibility of three rapid urease tests in the diagnosis of Helicobacter pylori infection. Dig Dis Sci. 2005; 50: 449-452.

  24. Lewis JD, Kroser J, Bevan J, Furth EE, Metz DC. Urease based tests for Helicobacter pylori gastritis. Accurate for diagnosis but poor correlation with disease severity. J Clin Gastroenterol. 1997; 25 (2): 415-420.

  25. Van Keeken N, Van Hattum E, de Boer WA. Validation of a new, commercially available dry rapid urease test for the diagnosis of Helicobacter pylori infection in gastric biopsies. Neth J Med. 2006; 64 (9): 329-333.

  26. Kumala W. Evaluation of the motility indole urease (MIU) test to detect Helicobacter pylori infection. Southeast Asian J Trop Med Public Health. 2006; 37 (5): 966-969.

  27. Siddique I, Al-Mekhaizeem K, Alateeqi N, Memon A, Hasan F. Diagnosis of Helicobacter pylori: improving the sensitivity of CLOtest by increasing the number of gastric antral biopsies. J Clin Gastroenterol. 2008; 42 (4): 356-360.

  28. Paniagua GL, Monroy E, Rodriguez R, Arroniz R, Rodríguez C, Cortés JL et al. Frequency of VacA, CagA, and babA2 virulence markers in Helicobacter pylori strains isolated from Mexican patients with chronic gastritis. Ann Clin Microbiol Antimicrob. 2009; 8: 14.

  29. Salimzadeh L, Bagheri N, Zamanzad B, Azadegan-Dehkordi F, Rahimian G, Hashemzadeh-Chaleshtori M et al. Frequency of virulence factors in Helicobacter pylori infected with gastritis. Microb Pathog. 2015; 80: 67-72.

  30. Rimbara E, Sasatsu M, Graham DY. PCR detection of Helicobacter pylori in clinical samples. Methods Mol Biol. 2013; 943: 279-287.

  31. Duś I, Dobosz T, Manzin A, Loi G, Serra C, Radwan-Oczko M. Role of PCR in Helicobacter pylori diagnostics and research —new approaches for study of coccoid and spiral forms of the bacteria. Postepy Hig Med Dosw (Online). 2013; 67: 261-268.

  32. Owen RJ. Molecular testing for antibiotic resistance in Helicobacter pylori. Gut. 2002; 50: 285-289.

  33. Minami M, Ohta M, Ohkura T, Ando T, Torii K, Hasegawa T et al. Use of a combination of brushing technique and the loop-mediated isothermal amplification methods a novel rapid, and safe system for detection of Helicobacter pylori. J Clin Microbiol. 2006; 44 (11): 4032-4037.

  34. Yari F, Abiri R, Aryan E, Ahmandi-Jouyhari T, Navadi J, Alvandi A5. Loop mediated isothermal amplification as a fast noninvasive method of Helicobacter pylori. J Clin Lab Annal. 2016; 30 (5): 464-470. doi:10.1002/jcla.21880.

  35. Samarabaf-Zandeh AR, Tajbakhsh S, Moosavian SM, Sadeghi Z. Application of fluorescent in situ hybridization (FISH) for the detection of Helicobacter pylori. Med Sci Monit. 2006; 12: CR426-430.

  36. Caristo E, Parola A, Rapa A, Vivenza D, Rasell B, Dondi E et al. Clarithromycin resistance of Helicobacter pylori strains isolated from children gastric antrum and fundus as assessed by fluorescent in situ hybridization and culture on four sector agar plates. Helicobacter. 2008; 13: 557-563.

  37. Monteiro L, de Mascarel A, Sarrasqueta AM, Bergey B, Barberis C, Talby P et al. Diagnosis of Helicobacter pylori infection: noninvasive methods compared to invasive methods and evaluation of two new tests. Am J Gastroenterol. 2001; 96: 353-358.

  38. Miftahussurur M, Yamaoka Y. Diagnostic methods of Helicobacter pylori infection for epidemiological studies: critical importance of indirect test validation. Biomed Res Int. 2016; 2016: 4819423.

  39. Undler GK, Ozgur GT, Gokturk HS, Durukan E, Erhamamnci S. Does the urea breath test predict eradication of Helicobacter pylori infection? Acta Gastroenterol Belg. 2016; 79: 3-7.

  40. Niv Y, Hazazi R. Helicobacter pylori recurrence in developed and developing countries: meta-analysis of 13C-urea breath test follow-up after eradication. Helicobacter. 2008; 13: 56-61.

  41. Peura DA, Pambianco DJ, Dye KR, Lind C, Frierson HF, Hoffman SR et al. Microdose 14C-urea breath test offers diagnosis of Helicobacter pylori in 10 minutes. Am J Gastroenterol. 1996; 91: 233-238.

  42. Masucci L, Blackhouse G, Goeree R. Cost-effectiveness of the carbon-13 urea breath test for the detection of Helicobacter pylori: an economic analysis. Ont Health Technol Assess Ser. 2013; 13: 1-28.

  43. Gisbert JP, Pajares JM. 13C-urea breath test in the diagnosis of Helicobacter pylori infection —a critical review. Aliment Pharmacol Ther. 2004; 20: 1001-1017.

  44. Burucoa C, Delchier JC, Courillon-Mallet A, de Korwin JD, Mégraud F, Zerbib F et al. Comparative evaluation of 29 commercial Helicobacter pylori serological kits. Helicobacter. 2013; 18: 169-179.

  45. Mégraud F. The most important diagnostic modalities for Helicobacter pylori, now and in the future. Eur J Gastroenterol Hepatol. 1997; 9: S13-S15.

  46. Harris P, Perez-Perez G, Zylberberg A, Rollán A, Serrano C, Riera F et al. Relevance of adjusted cut-off values in commercial serological immunoassays for Helicobacter pylori infection in children. Dig Dis Sci. 2005; 50: 2103-2109.

  47. Hirschl AM, Rotter ML. Serological tests for monitoring Helicobacter pylori eradication treatment. J Gastroenterol. 1996; 31: 33-36.

  48. Kato S, Tachikawa T, Ozawa K, Konno M, Okuda M, Fujisawa T et al. Urine-based enzyme-linked immunosorbent assay for the detection of Helicobacter pylori infection in children. Pediatrics. 2001; 107: E87.

  49. Hu HM, Kuo CH, Lo YC, Wu MT, Wu IC, Lu CY et al. Evaluation of the two immunochromatographic methods for detecting urine and serum IgG antibodies to Helicobacter pylori and comparison of accuracy and clinical utility. Hepatogastroenterology. 2007; 54: 119-123.

  50. Ballam LD, Mendall MA, Asante M, Morris J, Stranchan DP, Whincup PH et al. Western blotting is useful in the salivary diagnosis of Helicobacter pylori infection. J Clin Pathol. 2000; 53: 314-317.

  51. Parsonnet J, Shmuely H, Haggerty T. Fecal and oral shedding of Helicobacter pylori form healthy infected adults. JAMA. 1999; 282: 2240-2245.

  52. Kignel S, de Almeida PF, André EA, Alves MM, Birman EG. Occurrence of Helicobacter pylori in dental plaque and saliva of dyspeptic patients. Oral Dis. 2005; 11: 17-21.

  53. McNulty CA, Whiting JW. Patients’ attitudes to Helicobacter pylori breath and stool antigen tests compared to blood serology. J Infect. 2007; 55: 19-22.

  54. Gisbert JP, Pajares JM. Stool antigen test for the diagnosis of Helicobacter pylori infection: a systematic review. Helicobacter. 2004; 9: 347-368.

  55. Cullen KP, Broderick BM, Jayaram J, Flynn B, O’Connor HJ. Evaluation of the Helicobacter pylori stool antigen (HpSA) test in routine clinical practice —Is it patient-friendly? Ir Med J. 2002; 95: 305-306.

  56. Veijola L, Oksanen A, Löfgren T, Sipponen P, Karvonen AL, Rautelin H. Comparison of three stool antigen tests in confirming Helicobacter pylori eradication in adults. Scand J Gastroenterol. 2005; 40: 395-401.

  57. Pourakbari B, Mirsalehian A, Maleknejad P, Mamishi S, Azhdarkosh H, Daryani NE et al. Evaluation of a new antigen for diagnosis of Helicobacter pylori infection in stool of adult and children. Helicobacter. 2011; 16: 42-46.

  58. Choi J, Kim CH, Kim D, Chung SJ, Song JH, Kang JM et al. Prospective evaluation of a new stool antigen test for the detection of Helicobacter pylori, in comparison with histology, rapid urease test, (13)C-urea breath test, and serology. J Gastroenterol Hepatol. 2011; 26: 1053-1059.

  59. Patel SK, Pratap CB, Jain AK, Gulati AK, Nath G. Diagnosis of Helicobacter pylori: What should be the gold standard? World J Gastroenterol. 2014; 20: 12847-12859.

  60. Ernis F, Senocak Tasci E. Current Helicobacter pylori treatment in 2014. World J Methodol. 2015; 5: 101-107.

  61. Malfertheiner P, Megraud F, O’Morain CA, Atherton J, Axon AT, Bazzoli F et al. Management of Helicobacter pylori infection —the Maastricht IV/Florence Consensus Report. Gut. 2012; 61: 646-664.

  62. Papastergiou V, Georgopoulos SD, Karatapanis S. Treatment of Helicobacter pylori infection: Past, present and future. World J Gastrointest Pathophysiol. 2014; 5: 392-399.

  63. Lee JY, Kim N, Kim MS, Choi YJ, Lee JW, Yoon H et al. Factors affecting first-line triple therapy of Helicobacter pylori including CYP2C19 genotype and antibiotic resistance. Dig Dis Sci. 2014; 59: 1235-1243.

  64. Furuta T, Sugimoto M, Shirai N, Matsushita F, Nakajima H, Kumagai J et al. Effect of MDR1 C3435T polymorphism on cure rates of Helicobacter pylori infection by triple therapy with lansoprazole, amoxicillin and clarithromycin in relation to CYP2C19 genotypes and 23S rRNA genotypes of H. pylori. Aliment Pharmacol Ther. 2007; 26: 693-703.

  65. Urgesi R, Cianci R, Riccioni ME. Update on triple therapy for eradication of Helicobacter pylori: current status of the art. Clin Exp Gastroenterol. 2012; 5: 151-157.

  66. Bosques-Padilla FJ. A review of Helicobacter pylori diagnosis, treatment, and methods to detect eradication. World J Gastroenterol. 2014; 20: 1438-1449.

  67. Malfertheiner P, Selgrad M. Helicobacter pylori. Curr Opin Gastroenterol. 2014; 30: 589-595.

  68. Liang X, Xu X, Zheng Q, Zhang W, Sun Q, Liu W et al. Efficacy of bismuth-containing quadruple therapies for clarithromycin-, metronidazole-, and fluoroquinolone-resistant Helicobacter pylori infections in a prospective study. Clin Gastroenterol Hepatol. 2013; 11: 802-807.

  69. Venerito M, Krieger T, Ecker T, Leandro G, Malfertheiner P. Meta-analysis of bismuth quadruple therapy versus clarithromycin triple therapy for empiric primary treatment of Helicobacter pylori infection. Digestion. 2013; 88: 33-45.

  70. Molina IJ, Romano M, Fernandez BM, Federico A, Gravina AG, Pozzati L et al. Optimized non-bismuth quadruple therapies cure most patients with Helicobacter pylori infection in populations with high rates of antibiotic resistance. Gastroenterology. 2013; 145:121-128.

  71. Yuan Y, Ford AC, Khan KJ, Gisbert JP, Forman D, Leontiadis GI et al. Optimum duration of regimens for Helicobacter pylori eradication. Cochrane Database Syst Rev. 2013; 12: CD008337.

  72. Zullo A, Scaccianoce G, De Francesco V, Ruggiero V, D’Ambrosio P, Castorani L et al. Concomitant, sequential, and hybrid therapy for H. pylori eradication: a pilot study. Clin Res Hepatol Gastroenterol. 2013; 37: 647-650.

  73. McNicholl AG, Marin AC, Molina-Infante J, Castro M, Barrio J, Ducons J et al. Randomised clinical trial comparing sequential and concomitant therapies for Helicobacter pylori eradication in routine clinical practice. Gut. 2014; 63: 244-249.

  74. De Francesco V, Hassan C, Ridola L, Giorgio F, Ierardi E, Zullo A. Sequential, concomitant and hybrid first-line therapies for Helicobacter pylori eradication: a prospective randomized study. J Med Microbiol. 2014; 63:748-752.

  75. Sardarian H, Fakheri H, Hosseini V, Taghvaei T, Maleki I, Mokhtare M. Comparison of hybrid and sequential therapies for Helicobacter pylori eradication in Iran: a prospective randomized trial. Helicobacter. 2013; 18: 129-134.

  76. Zheng X, Lyu L, Mei Z. Lactobacillus-containing probiotic supplementation increases Helicobacter pylori eradication rate —evidence from a meta-analysis. Rev Esp Enferm Dig. 2013; 105: 445-453.

  77. Song MJ, Park DI, Park JH, Kim HJ, Cho YK, Sohn CI et al. The effect of probiotics and mucoprotective agent on PPI-based triple therapy for eradication of Helicobacter pylori. Helicobacter. 2010; 15: 206-213.

  78. D’Elios MM, Czinn SJ. Immunity, inflammation, and vaccines for Helicobacter pylori. Helicobacter. 2014; 1: 19-26.

  79. Milani M, Sharifi Y, Rahmati-Yamchi M, Somi MH, Akbarzadeh A. Immunology and vaccines and nanovaccines for Helicobacter pylori. Exper Rev Vaccines. 2015; 14: 833-840.

  80. Zhou Z, Gong S, Li-XM, Yang Y, Guan R, Zhou S et al. Expression of Helicobacter pylori urease B on the surface of Bacillus subtilis spores. J Med Microbiol. 2015; 64: 104-110.

  81. Walduck A, Andersen LP, Raghavan S. Inflammation, immunity and vaccines for Helicobacter pylori infection. Helicobacter. 2015; 1: 17-25.

  82. Zhang S, Moise L, Moss SF. Helicobacter pylori vaccines: why we still don’t have any. Human Vaccine. 20111; 7: 1153-1157.

  83. Wang B, Pan X, Wang H, Zhou J, Yang J, Li W. Immunological response of recombinant H. pylori multi-epitope vaccine with different vaccination strategies. Int J Clin Exp Pathol. 2014; 7: 6559-6566.

  84. Anderl F, Gerhard M. Helicobacter pylori vaccination is a path to protection. World J Gastroenterol. 2014; 20: 11939-11949.




2020     |     www.medigraphic.com